LYTTON LAURENCE W 13D and 13G filings for TFF Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 6:48 pm Sale |
2023-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
LYTTON LAURENCE W | 11,900 0.100% |
-113,129 (-90.48%) |
Filing |
| 2023-02-13 4:03 pm Sale |
2022-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
LYTTON LAURENCE W | 125,029 8.400% |
-477 (-0.38%) |
Filing |
| 2022-11-23 1:01 pm Purchase |
2022-11-18 | 13G | TFF Pharmaceuticals, Inc. TFFP |
LYTTON LAURENCE W | 125,506 8.800% |
125,506 (New Position) |
Filing |